Last updated on September 2018

Efficacy and Safety of Low Dose Thalidomide in Thalassemia Intermedia

Brief description of study

Thalidomide is known to have hypnosedative, immuno-modulatory and anti-angiogenic effects. The drug is widely used in several neoplastic disorders (e.g. multiple myeloma and malignant melanoma), inflammatory conditions (e.g. Crohn's disease) and skin disorders (e.g. leprosy). Thalidomide has been successfully used in adult thalassemia patients. The current study explores its role in younger thalassemia patients.

Clinical Study Identifier: NCT03651102

Contact Investigators or Research Sites near you

Start Over

Muhammad Tariq M Khan

Blood Diseases Clinic
Peshawar, Pakistan
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.